Petra Kaufmann
Company: Affinia Therapeutics
Job title: Chief Medical Officer
Seminars:
Panel Discussion: Dose Optimization for Neurological Gene Therapies 12:15 pm
Determining Optimal Dose & Considering Disease Progression for Time of Intervention 11:35 am
Determining the dose for first-in-human gene therapy studies Considering the best route of administration Understanding disease progression to optimize the timing of interventionRead more
day: Day One: Track B AM